Change of Director's Interest Notice - Stamler
Released
Released
Announcement PDF
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX
becomes ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for
the purposes of section 205G of the Corporations Act.
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Appendix 3Y
Change of Director's Interest Notice
Name of entity Alterity Therapeutics Limited
ABN 37 080 699 065
Name of director David Stamler
Date of last notice 06 January 2026
Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
HSBC CUSTODY NOMINEES (AUSTRALIA)
LIMITED - 139,258 AMERICAN DEPOSITARY
SHARES (equivalent to 1,671,096 FULLY PAID
ORDINARY SHARES)
Date of change (1) N/A
(2) 31 August 2026
(3) N/A
(4) N/A
(5) N/A
(6) N/A
No. of securities held prior to change (1) 233,767 - FULLY PAID ORDINARY SHARES -
DIRECT
(2) 47,620 - LISTED OPT EXP 31/08/2026 @ $0.50
- DIRECT
(3) 30,304 - LISTED OPT EXP 26/02/2027 @ $1.40
- DIRECT
(4) 800,004 - UNLISTED OPT EXP 21/03/2029 @
US$0.15 - DIRECT
(5) 5,808,000 - UNLISTED OPT EXP 08/08/2030 @
US$0.43 - DIRECT
(6) 139,258 - AMERICAN DEPOSITARY SHARES
(equivalent to 1,671,096 FULLY PAID ORDINARY
SHARES) - INDIRECT
Class (1) FULLY PAID ORDINARY SHARES
(2) LISTED OPT EXP 31/08/2026 @ $0.50
(3) LISTED OPT EXP 26/02/2027 @ $1.40
(4) UNLISTED OPT EXP 21/03/2029 @ US$0.15
(5) UNLISTED OPT EXP 08/08/2030 @ US$0.43
(6) AMERICAN DEPOSITARY SHARES
+
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Part 2 - Change of director's relevant interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be
disclosed in this part.
Part 3 - +Closed period
Appendix 3Y
Change of Director's Interest Notice
Number acquired (1) NIL
(2) NIL
(3) NIL
(4) NIL
(5) NIL
(6) NIL
Number disposed (1) NIL
(2) 47,620 LISTED OPT EXP 31/08/2026 @ $0.50
(3) NIL
(4) NIL
(5) NIL
(6) NIL
Value/Consideration (1) N/A
(2) N/A
(3) N/A
(4) N/A
(5) N/A
(6) N/A
No. of securities held after change (1) 233,767 - FULLY PAID ORDINARY SHARES -
DIRECT
(2) NIL - LISTED OPT EXP 31/08/2026 @ $0.50 -
DIRECT
(3) 30,304 - LISTED OPT EXP 26/02/2027 @ $1.40
- DIRECT
(4) 800,004 - UNLISTED OPT EXP 21/03/2029 @
US$0.15 - DIRECT
(5) 5,808,000 - UNLISTED OPT EXP 08/08/2030 @
US$0.43 - DIRECT
(6) 139,258 - AMERICAN DEPOSITARY SHARES
(equivalent to 1,671,096 FULLY PAID ORDINARY
SHARES) - INDIRECT
Nature of change (1) N/A
(2) Options expired
(3) N/A
(4) N/A
(5) N/A
(6) N/A
Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities
to which interest related
prior to change
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Interest after change N/A
+
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 2
Appendix 3Y
Change of Director's Interest Notice
Were the interests in the securities or
contracts detailed above traded during a
+
closed period where prior written clearance
was required?
No.
If so, was prior written clearance provided to
allow the trade to proceed during this period?
N/A
If prior written clearance was provided, on
what date was this provided?
N/A
+
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Share your feedback
Discover